Roughly half of Parkinson\u2019s patients suffer from frightening extracampine hallucinations (EH). Unusually high dopamine levels are usually responsible. In many cases, these hallucinations of animals or deceased individuals are extremely unsettling and almost debilitating. Parkinson\u2019s hallucinations often touch almost every sensory nerve. Patients do not simply see things that are not there. These patients with hallucinations sometimes see, hear, taste, and smell things that are not there.<\/p>\n
Despite the nature and scope of the problem, there was no effective EH treatment until the Food and Drug Administration hastily approved Nuplazid in 2016. By 2017, sales eclipsed $125 million. Nuplazid\u2019s maker, San Diego-based Acadia Pharmaceuticals, expects sales to double in 2018. But there are serious concerns about the drug\u2019s effectiveness, and more importantly, its Sicherheit<\/a>.<\/p>\n Congress created the FDA\u2019s controversial expedited approval avenues to essentially short-circuit the agency\u2019s mission. Instead of taking the time necessary to help ensure safety and effectiveness, industry insiders can take advantage of legal loopholes to rush potentially unsafe drugs to market. If the FDA process fails to protect patients, aggressive and experienced Rechtsanw\u00e4lte f\u00fcr Neapel<\/a> nehmen Sie die L\u00fccke. Wir k\u00e4mpfen f\u00fcr eine maximale Entsch\u00e4digung in diesen Nuplazid-Klagen. Dar\u00fcber hinaus haben wir die Ressourcen, um Sie zu unterst\u00fctzen. Opfer von schlechten Drogen k\u00f6nnen darauf vertrauen, dass Napoli Law sowohl im Gerichtssaal als auch am Verhandlungstisch als starke Stimme dient.<\/p>\n <\/p>\n Nuplazid (Pimavanserin) ist ein orales Medikament. Bei $100 pro Dosis kann es Parkinson-Patienten leicht $30.000 pro Jahr kosten. Nuplazid ist auch ein sehr starkes Medikament. Da EH so viele verschiedene Sinne beeinflusst, muss das Medikament sowohl das Gehirn als auch die Sinne auf verschiedene Weise beeinflussen.<\/p>\n Einige h\u00e4ufige Nebenwirkungen sind:<\/strong><\/p>\n <\/p>\n Depending on the patient, these mild to moderate side-effects usually dissipate once the body adjusts to the medicine.<\/p>\n The potential serious side effects of this powerful medication are what really concerns doctors and other researchers. These serious and possibly fatal side effects include:<\/p>\n Andere m\u00f6gliche Nebenwirkungen sind schwere Hautausschl\u00e4ge, \u00fcberm\u00e4\u00dfige M\u00fcdigkeit, Engegef\u00fchl im Hals und Harnwegsinfektionen. Bisher wurde Nuplazid mit \u00fcber 240 Todesf\u00e4llen in Verbindung gebracht. Das ist eine astronomische Zahl potenzieller Todesf\u00e4lle, wenn man bedenkt, dass Pimavanserin erst seit 2016 erh\u00e4ltlich ist.<\/p>\n <\/p>\n Im Durchschnitt verbringen neue Medikamente etwa ein Dutzend Jahre in der Genehmigungspipeline<\/a>. This area has been a bone of contention for years. Safety advocates claim that the time delay helps ensure that new drugs are safe.<\/p>\n Meanwhile, industry lobbyists have loudly complained that the Verfahren<\/a> is too long. A new drug patent usually lasts twenty years. The clock begins ticking when the drug is discovered and not when it is available for sale. So, drug makers may have only about eight years to recoup their extensive development costs, which could exceed $2.5 billion, and show a healthy profit.<\/p>\n Congress eventually listened to well-paid lobbyists as opposed to safety advocates and revised the approval process. But rather than addressing the issue directly, lawmakers sidestepped the question. They created two controversial approval shortcuts.<\/p>\n Auch der normale Genehmigungsprozess bietet keine Sicherheit. Die FDA erh\u00e4lt einen wesentlichen Teil ihres Budgets von der Pharma- und Medizinprodukteindustrie. Dar\u00fcber hinaus sind viele Menschen bereits schwer verletzt, als die langsame FDA einen R\u00fcckruf herausgibt.<\/p>\n <\/p>\n Nuplazid claims are very complex. They are theoretically easy to win, but very difficult to win in practice.<\/p>\n The burden of proof in these tort cases is usually a preponderance of the evidence, a legal term which means \u201cmore likely than not.\u201d If the scales of justice tip ever so slightly in the plaintiff\u2019s favor, the plaintiff prevails on that particular element. This is the lowest standard of proof in the law.<\/p>\n These cases almost always require expert witnesses. To evaluate these witnesses, New York courts use the more well-established Frye-Standard<\/a>. Im Allgemeinen m\u00fcssen ihre Meinungen nur vern\u00fcnftig sein, damit sie vor der Jury aussagen k\u00f6nnen. Andere Staaten verwendeten den intensiveren Daubert-Standard.<\/p>\n <\/p>\n pharmaceutical and medical device companies have nearly unlimited resources. They hire top professional witnesses who testify that the device or drug is entirely safe. Furthermore, these cases are based on inductive reasoning (a limited amount of information) as opposed to deductive reasoning (a large body of data).<\/p>\n Therefore, to obtain fair compensation in these cases, victim\/plaintiffs and their family members need tenacious and highly-skilled attorneys.<\/p>\nWas ist Nuplazid?<\/h2>\n
\n
\n
Der FDA-Zulassungsprozess<\/h2>\n
\n
Ihr Anspruch auf Schadensersatz<\/h2>\n
Einreichung einer Nuplazid-Klage<\/h2>\n